SCHEMBL3714898

SCHEMBL3714898

CC(C)(C)OC(=O)NCCCCC(=O)c1ccc(Cl)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
STK17B O94768 1/20 0.42
STK17A Q9UEE5 1/20 0.42
DRD2 P14416 5/20 0.42
CYP3A4 P08684 1/20 0.42
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
IDO1 P14902 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4967914 0.86 TDP1 (0.44) TDP1CYP3A4CA1CA2CA12
SCHEMBL30722163 0.86 TDP1 (0.44) TDP1CYP3A4CA1CA2CA12
SCHEMBL2705787 0.84 TDP1 (0.49) TDP1CYP3A4CA1CA2CA12
SCHEMBL205459 0.82 CA1 (0.45) TDP1CYP3A4CA1CA2CA12
SCHEMBL29925130 0.82 CA1 (0.45) TDP1CYP3A4CA1CA2CA12
SCHEMBL24746443 0.80 CA1 (0.45) TDP1DRD2CYP3A4CA1CA2
SCHEMBL29891357 0.80 CA1 (0.45) TDP1DRD2CYP3A4CA1CA2
SCHEMBL17410238 0.80 CA1 (0.48) TDP1DRD2CYP3A4ALDH1A1PKM
SCHEMBL24350075 0.79 NPC1 (0.54) TDP1TSHRCA1CA2CA12
SCHEMBL28577976 0.78 MGLL (0.50) TDP1DRD2CYP3A4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138490-A1 BENZOXAZEPINES AS INHIBITORS OF MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2010-12-02 WO disclosed